Torrent Pharma’s (Torrent) Q2FY23 performance was broadly in line with our estimates with revenue growing 7.2% YoY to Rs22.9bn and EBITDA margin at 29.6% (I-Sec: 30%). India grew 12.6% YoY while Brazil grew 18.6% YoY.